Navigation Links
Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results
Date:11/24/2008

SOPHIA ANTIPOLIS, France, November 24 /PRNewswire-FirstCall/ -- NicOx S.A. (NYSE Euronext Paris: COX) today announced that the third pivotal phase 3 study for naproxcinod in patients with OA of the hip showed a highly statistically significant result (p<0.001) on all three co-primary efficacy endpoints of the trial. Naproxcinod 750 mg bid showed the same gastrointestinal (GI) adverse event rate and a similar blood pressure profile to placebo. Naproxcinod is the most advanced compound in a novel class of anti-inflammatory agents known as Cyclooxygenase-Inhibiting Nitric Oxide Donators (CINODs).

Following the positive results from the 301 and 302 studies in patients with OA of the knee, 303 represents the third phase 3 study for naproxcinod to achieve p<0.001 on all three co-primary efficacy endpoints. The 303 study is also the final pivotal trial that NicOx plans to include in the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) in mid-2009.

"This study has demonstrated clear-cut efficacy for naproxcinod 750 mg bid in hip OA, in addition to providing reassuring blood pressure and safety data," said Thomas J. Schnitzer, MD, PhD, Professor of Medicine at Northwestern University Feinberg School of Medicine, who advised NicOx on the design and analysis of the trial. "Meeting the primary endpoints of this study is a significant achievement, considering the difficultly in controlling the symptoms of hip OA patients. Few studies with other anti-inflammatory agents have focused only on people with hip OA, in part because of the increased difficulty in demonstrating efficacy in this population compared to knee OA. Additionally, the fact that the blood pressure data for naproxcinod and placebo were similar at all time points is also encouraging, as there is a definite need for new anti-inflammatory agents that do not increase blood pressure."

Result
'/>"/>

SOURCE NicOx
Copyright©2008 PR Newswire.
All rights reserved

13611

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Over $10 Million of CSL Behrings Privigen Was Sold in the U.S. During the Third Quarter of 2008
2. SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
3. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
4. CuraGen to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and CR011-vcMMAE Phase II Trial Results on November 3, 2008
5. Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent
6. Physicians Estimate That if Approved, Ceftobiprole Will Steal Nearly a Third of Zyvoxs Patient Share in the Treatment of Nosocomial Pneumonia
7. NewCardio Announces Positive Results From Third Clinical Validation Study
8. Transcept Pharmaceuticals Announces Intent to Submit New Drug Application for Intermezzo(R) in Third Quarter 2008
9. NicOx Completes Patient Enrollment in Third Naproxcinod Pivotal Phase 3 Study
10. NeoStem Reports Positive Stem Cell Industry Research Trends From The Journal of the American Medical Association and Third Annual Stem Cell Summit
11. Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...ll/ -- Volcano Corporation (Nasdaq: VOLC ), a lea...roducts for the diagnosis and treatment of coronar...t will be participating in the Third Annual Canacc... 10. ,, The presentation by Scott Huennekens, p...t 1 p.m., Pacific Standard Time (4 p.m., Eastern S...
(Date:11/9/2009)...rstCall/ -- Hologic, Inc. (Hologic or the Company)...er and supplier of premium diagnostics, medical im...erving the healthcare needs of women, today announ...year ended September 26, 2009. In addition, Hologi...ted Robert Cascella to Chief Executive Officer eff...
(Date:11/9/2009)...wire/ -- Momentum is building for the early Decem...second P-MEC India pharma ingredients, services an...00 exhibitors from over 80 countries are expec...vents, being held on 1 - 3 December. ,, In add...include two new launches. BioPh India will focus...
Breaking Medicine Technology:Volcano Corporation Presentation at Canaccord Adams Conference to Be Webcast 2Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 2Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 3Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 4Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 5Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 7Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 8Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 9Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 10Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 11Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 12Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 13Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 14Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 15Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 16Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 17Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 18Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 19Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 20Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 21Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 22Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 23Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 24Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 25Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 26Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 27Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 28Forecast Looks Good for India Pharma Shows 2Forecast Looks Good for India Pharma Shows 3Estrogen Plays Surprise Role in Breast Cancer Treatment 54789 1Estrogen Plays Surprise Role in Breast Cancer Treatment 54789 2Estrogen Plays Surprise Role in Breast Cancer Treatment 54789 3American Community Mutual Insurance Company 28ACMIC 29 Selects Corticon 54785 1American Community Mutual Insurance Company 28ACMIC 29 Selects Corticon 54785 2American Community Mutual Insurance Company 28ACMIC 29 Selects Corticon 54785 3American Community Mutual Insurance Company 28ACMIC 29 Selects Corticon 54785 4American Podiatric Medical Association Corrects Presidents Misstatement on Foot Amputation Costs 54780 1American Podiatric Medical Association Corrects Presidents Misstatement on Foot Amputation Costs 54780 2
...HASE 3 CLINICAL TRIAL FOR NATURLOSE(R) ANTICIPATED...orporated (Nasdaq: SPEX ), an innovator in biote...y consulting services to food, supplement, biotech...ed the postponement of its 2009 Annual Shareholder...ing will instead be held during the Fall of 2009, ...
... 11 Premier Research Group Limited, the internati...ce that it has expanded their medical device opera...s. Their dedicated medical device group has been o...997 and is considered an industry leader for manag... , "Our clients have requested expanded medical d...
Other Medicine Technology:Spherix Postpones 2009 Annual Shareholders Meeting to Share Interim Diabetes Clinical Trial Data 2Spherix Postpones 2009 Annual Shareholders Meeting to Share Interim Diabetes Clinical Trial Data 3Premier Research Expands its Medical Device Operations to the United States 2
(Date:11/9/2009)...ident Obama,s promise to not expand abortion ,...s still concerned for poor, elderly ,, WASHING...ancis George of Chicago, president of the United S...ovember 7 decision of the U.S. House of Representa...om paying for elective abortions. ,, In a stat...
(Date:11/9/2009)...ying Genetic Variance Across the World is Critical... (Vocus) November 9, 2009 -- Unders...inarily valuable when analyzing and interpreting s...udy that scanned the genomes of 4,000 people throu... Drs. Chao Tian and Michael F. Seldin of the Unive...
(Date:11/9/2009)...ls regained sexual function, study says, , ...hers were able to restore sexual function to rabbi...ue in the lab and implanting it, a new study repor... researchers say the technique could one day be us..., "We were able to show the tissue was able to in...
(Date:11/9/2009)...se, to be Offered in April 2010, Provides First Re... Cambridge, MA (Vocus) November 9, 2009 -...ts (PHR) first inspected a suspected mass grave a...uld need a team of experts to help interpret the s...as a key first step in securing evidence of a huma...
(Date:11/9/2009)...010 National Ambassador ,, WHITE PLAINS, N.Y.... of Weston, Fla., was born so early and with so ma...y whether he would survive -- or if he would ever ... named March of Dimes 2010 National Ambassador. ,...irst minutes of motherhood and I was completely de...
Breaking Medicine News(10 mins):Health News:Cardinal George Lauds House Action to Ban Federal Funds for Abortion; Promises Vigilance as Senate Pursues Health Care Reform, Wary About Affect on Poor, Elderly 2Health News:Cardinal George Lauds House Action to Ban Federal Funds for Abortion; Promises Vigilance as Senate Pursues Health Care Reform, Wary About Affect on Poor, Elderly 3Health News:News from the November/December Issue of Molecular Medicine 2Health News:Scientists Grow New Penile Tissue in the Lab 2Health News:Scientists Grow New Penile Tissue in the Lab 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 2Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 4Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 2Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 3
...ssionals and exhibitors registered for the,first-e... CHICAGO, Oct. 17 With studies from the,National...r of students and,adults enrolling in distance edu... conference on Nov. 6-7. The HIMSS,Virtual Confere...
... Pressure Cuff and Weight Scale Added to Our ...ALLEY, Calif., Oct. 18 XTend Medical,Corporation ...d two new,Bluetooth(R) enabled telemedicine produc... of A & D,s Bluetooth(R) enabled Blood Pressure Cu...
...ble in French . , A new study led by McGill Univ...irus (HPV) screening test is far more accurate tha...ancer. The first round of the Canadian Cervical Ca...hat the HPV test,s ability to accurately detect pr...
...to think of scientists in laboratories working tow... other laboratory animals, but animals roles in at...inimal. , Researchers at the University of Misso... discarded that mimics arthritic joints. This "joi...
...alifornia Science,Center,s Science Matters speaker...Fear" in a free program from 1 - 3:30 p.m. on Satu...will discuss the current science of,fear, which fe...ipulated by the media. Speakers will also address ...
...al Football League,(NFL), National Hockey League (...iation (NHLPA) have agreed to sponsor an education...National Academy of Neuropsychology (NAN) and,the ...rs, parents, physicians and coaches, and will prov...
Other Medicine News:Health News:HIMSS' Second Virtual Conference & Expo Less Than a Month Away 2Health News:HIMSS' Second Virtual Conference & Expo Less Than a Month Away 3Health News:HIMSS' Second Virtual Conference & Expo Less Than a Month Away 4Health News:XTend Medical (XDMC) Adds New Bluetooth(R) Telemedicine Products From A&D Medical 2Health News:Study: HPV test beats Pap in detecting cervical cancer 2Health News:Study: HPV test beats Pap in detecting cervical cancer 3Health News:In vitro models will minimize animal use in arthritis studies 2Health News:NFL, NHL and NHLPA Team Up in Sports Concussion Education Campaign 2
Clear Pb Mobile Barriers
Mobile Protective Shield
Thyro Guard
MAX Guard
Medicine Products: